TheEdgeResearch
Home / Stocks / MOTS

Motus GI Holdings, Inc. (MOTS)

OTC Healthcare Medical - Devices
$0.00 ▲ +0.00%
Market Cap
$639
Sector
Healthcare
Industry
Medical - Devices
Beta
-5.87
52-Wk Range
0.00001-0.1
CEO
Mark Pomeranz
Country
US
Currency
USD

Motus GI Holdings, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Fort Lauderdale, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $639. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -4033.5%. Its beta of -5.87 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
0.22
Gross margin
-78.4%
Operating margin
-3732.6%
Net margin
-4033.5%
Return on equity
Debt / equity
0.92
Current ratio
1.76
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
15
IPO date
2018-02-14
Headquarters
Fort Lauderdale, FL, US
About Motus GI Holdings, Inc.

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Comparable companies

Motus GI Holdings, Inc. is most often compared with the following Healthcare names:

ATRXBIIOCNNXFGBIMHRALIMRSQMICRDONCSQROSGQSTBV
More research on MOTS
MOTS technical analysis MOTS TheEdge Score Compare against peers
Open full interactive analysis & DCF →